Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01794507
Title A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie (prior sponsor, Abbott)
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA | AUS

Facility Status City State Zip Country Details
University of Arizona Cancer Center - North Campus /ID# 117876 Tucson Arizona 85719-1478 United States Details
Mayo Clinic /ID# 121495 Jacksonville Florida 32224 United States Details
Northwestern University Feinberg School of Medicine /ID# 117477 Chicago Illinois 60611-2927 United States Details
University of Michigan Hospitals /ID# 80353 Ann Arbor Michigan 48109 United States Details
Mayo Clinic - Rochester /ID# 77235 Rochester Minnesota 55905-0001 United States Details
Peter MacCallum Cancer Ctr /ID# 79553 Melbourne Victoria 3000 Australia Details
Royal Melbourne Hospital /ID# 79533 Parkville Victoria 3050 Australia Details
CHRU Lille - Hôpital Claude Huriez /ID# 77234 Lille CEDEX Hauts-de-France 59045 France Details
CHU de Nantes, Hotel Dieu -HME /ID# 78773 Nantes 44093 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field